Furthermore, a comprehensive and careful analysis of anti-AFP CD8 T-cell responses by Thimme et al (2008) demonstrated that anti-AFP CD8 T-cell responses are detectable in controls and in HCC patients (Thimme et al, 2008). This evidence concerns the gene AFP and hepatocellular carcinoma.